TP53 and cancer: As this senescent-like phenotype in cancer cells occurs in largely dysfunctional cells for their cell cycle regulation, i.e. p53 mutations [33], it is probable that senescent-like cancer cells are more prone to reproliferate when exposure to therapeutic stress ends, increasing the risk of relapse of these treated cells.